Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center for Adults Aged 65 Years or Older or Those With Defined Risk Factors for Invasive Pneumococcal Disease
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 203
- 试验地点
- 2
- 主要终点
- Knowledge and Awareness of Pneumococcal Disease
研究概览
简要总结
The overall goals of this program are to measure the impact of a pharmacist pneumococcal vaccine education program (PPVP) using a senior center model of care and provide the pneumococcal vaccine to eligible participants.
Hypotheses
- PPVP will result in improved knowledge and awareness in older minorities in the senior center setting (primary hypothesis);
- Participants who are vaccinated through the project will experienced increased trust in receiving vaccines from a pharmacist;
- Participants will be satisfied with and trust the PV information provided by pharmacists in the PPVP;
- PPVP is an efficient approach to educating patients in the senior center based on its costs;
- Participating pharmacists will be activated to implement PPVP learnings in their practice.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •A. Inclusions for PPVP:
- •Age ≥ 50 years old
- •Can attend a 1.5-hour session at CIP
- •Cognitively intact based on responses to an Abbreviated Mental Test Score (AMTS) of ≥7 (see Appendix for AMTS instrument)
- •Can speak and read English at ≥4th grade level as evidenced by ability to read a brief passage
- •Access to a telephone
- •B. Inclusions to receive the optional pneumococcal vaccination:
- •Patient meets ≥1 of the following criteria for receiving their first pneumococcal vaccination:
- •All adults age 65 years and older who have not had the vaccine previously
- •Age 50-64 years with any of the following conditions:
- •Cigarette smokers age 19 years and older
- •Chronic cardiovascular disease (e.g., congestive heart failure, cardiomyopathies; excluding hypertension)
- •Chronic pulmonary disease (including COPD and emphysema, and for adults ages 19 years and older, asthma)
- •Diabetes mellitus
- •Chronic liver disease, cirrhosis
- •Candidate for or recipient of cochlear implant
- •Functional or anatomic asplenia (e.g., sickle cell disease, splenectomy)
- •Immunocompromising conditions or on immunosuppressive therapy
- •Chronic renal failure or nephrotic syndrome
- •Patient meets ≥1 of the following criteria for receiving a booster dose of the pneumococcal vaccination:
- •Adults age 65 years and older who received their first dose for any indication when they were younger than age 65 years.
- •Adults age 50-64 who have not received the vaccine for ≥5 years and have one of the following conditions:
- •Functional or anatomic asplenia (including persons with sickle cell disease or splenectomy patients);
- •Chronic renal failure (including dialysis patients) or nephrotic syndrome;
- •Immunocompromising conditions or on immunosuppressive therapy
排除标准
- •A. Exclusions to the PPVP program: none
- •B. Exclusions to receiving the optional pneumococcal vaccine:
- •Participant has a history of allergic reaction to pneumococcal vaccine
- •Participant has a history of allergic reaction to any component of any vaccine
- •Participant with moderate or severe illness (these individuals will be advised to speak to their doctor regarding the vaccine)
结局指标
主要结局
Knowledge and Awareness of Pneumococcal Disease
时间窗: Baseline, post-test, 3 months
Change in knowledge and awareness of pneumococcal disease over time were assessed for the following domains: susceptibility to infection, symptoms of disease, severity of illness, and vaccination with an emphasis on vaccine efficacy, safety, and eligibility. Assessments at baseline, post-test (immediately following intervention), and 3 months using the Pneumonia Knowledge Questionnaire, an instrument developed by investigators to assess participants' knowledge and awareness in the domains of interest. Instrument consists of 5 "mark all that apply" items and one "mark the best response" item. Scores range from 0 (no correct responses) to 28 (all responses correct), with a higher score value corresponding to better knowledge and awareness.
次要结局
- Activation(3 months)
- Intervention Cost(3 months)
- Pharmacist Satisfaction(3 months)
- Satisfaction With PPPP(3 months)
- Trust in Pharmacists as Vaccine Providers(Baseline, post-test (immediately following intervention), 3 months)